English
+38 068 889 89 89
00380689869898 (汉语)
00380930552240 (باللغة العربية)
00380930552240 (باللغة العربية)
+38 044 223 28 95
Contact us

Arterial Hypertension

According to medical statistics, arterial hypertension, or elevated blood pressure, is the main cause of death all over the world along with cerebral atherosclerosis. EmCell offers fetal stem cell therapy in a combined treatment of arterial hypertension aimed at improving the condition of arterial walls and blood pressure stabilization.

At Cell Therapy Center EmCell, patients with primary arterial hypertension with frequent arterial crises receive transplantation of fetal stem cells of ectodermal and mesenchymal origin. Stem cells administered into recipient’s body get into the cardiac muscle and produce various biologically active substances, such as growth factors, cytokines, etc., which results in improved heart functioning. Under the influence of the microenvironment, mesenchymal stem cells develop into a phenotype of cardiomyocytes. Pre-neuronal stem cells normalize nervous vascular control resulting in crisis prevention. That is why cell therapy can be used to restore the functional properties of the heart muscle.

Prior to transplantation, continuous hypotensive therapy regimen is selected; that allows for preventing hypertensive crises, and diastolic pressure stabilizes at the level no higher than 90 mm Hg.

Stem cell therapy allows to completely restore the integrity of the vascular tissues, their elasticity, conductivity and strength at the biological level. It has the following positive effects in treatment of arterial hypertension:

  • vascular system improvement: stem cells begin to produce angiogenic and anti-inflammatory factors;
  • partial replacement of destroyed or damaged cells;
  • improved cerebral vessel functioning and cardiac blood supply;
  • increased elasticity and permeability of blood vessels;
  • improved delivery of oxygen and nutritional elements to all organs and tissues—brain, heart, liver, kidneys—due to better blood flow.

Within 3–5 months after fetal stem cell transplantation, all patients demonstrate stable decline in blood pressure and reduction of hypotensive therapy by approximately 50%. 

All patients note positive treatment effects such as disappearance of headache, stabiliziation and normalization of blood pressure and sleep, improved mental ability and sexual potency (both in men and women), return of vivacity – signs of rejuvenation.

Thus, stem cell therapy improves the condition of the vascular system of the human body. Full disclosure of stem cells’ regenerative potential usually occurs within 2-3 months after transplantation. To intensify the effects of cell therapy, patients are advised to improve lifestyle, get rid of bad habits, decrease intake of salt and start exercising.

 

Fetal Stem Cells in Post-Stroke Cognitive Deficit.
Poster session.

Request additional information
Fetal stem cells treatment results depend on: disease's severity, age of the patient, adherence for the medications and regime. Treatment results, presented on this site, are individual for each clinical case.

Our stories

Our patents